EMD-12530

Subtomogram averaging
11.6 Å
EMD-12530 Deposition: 02/03/2021
Map released: 07/04/2021
Last modified: 07/04/2021
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-12530

Archive Files (Depositor)

Primary 3D volume (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

Subtomogram average of ChAdOx1 nCoV-19/AZD1222 derived SARS-CoV-2 spike glycoprotein

EMD-12530

Subtomogram averaging
11.6 Å
EMD-12530 Deposition: 02/03/2021
Map released: 07/04/2021
Last modified: 07/04/2021
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: Severe acute respiratory syndrome coronavirus 2

Deposition Authors: Watanabe Y, Mendonca LM, Allen ER, Howe A, Lee M, Allen JD, Chawla H, Pulido D, Donnellan F, Davies H, Ulaszewska M, Belij-Rammerstorfer S, Morris S, Krebs AS, Dejnirattisai W, Mongkolsapaya J, Supasa P, Screaton GR, Green CM, Lambe T, Zhang P, Gilbert SC, Crispin M
Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine.